Breast Cancer Coverage from Every Angle

Marleen Kok, MD, PhD, on Luminal Breast Cancer: Immunotherapy Strategies

Posted: Monday, November 5, 2018

Marleen Kok, MD, PhD, of The Netherlands Cancer Institute, discusses some possible solutions to the problem that only a few patients with luminal breast cancer respond to current immunotherapies: giving immunotherapy earlier in the course of the disease or using combination immunotherapies.

By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn more.